Lower cardiac output has been tied to poorer cerebral blood flow (CBF) in the temporal lobes of older adults without heart failure, a finding that adds to a growing body of research linking heart ...

A naturally occurring fat molecule reduced heart inflammation and scarring caused by diabetes, thereby improving cardiac function, according to new research. The findings open the door to developing a ...

Researchers have reduced scar formation and improved heart function in mouse models of heart failure using a monoclonal antibody treatment, similar to that approved by the FDA to treat other ...

Maintaining a stable heartbeat is critical for survival. Your heart must constantly adapt its output to meet changing demands ...

Researchers at the Nora Eccles Harrison Cardiovascular Research and Training Institute, University of Utah, and the University of Utah School of Medicine, have demonstrated that a gene therapy can ...

A new gene therapy can reverse the effects of heart failure and restore heart function in a large animal model. The therapy increases the amount of blood the heart can pump and dramatically improves ...

Cardiologists and radiation oncologists at Washington University School of Medicine in St. Louis pioneered the use of radiation therapy - a strategy typically used against cancer - to treat patients ...

Please provide your email address to receive an email when new articles are posted on . Danicamtiv was well tolerated and improved heart function in certain patients with dilated cardiomyopathy. Those ...

The tiny, floating blobs of mini-hearts were straight out of Frankenstein. Made from a mixture of human stem cells and a sprinkle of silicon nanowires, the cyborg heart organoids bizarrely pumped away ...

Increasing ketone supply to the heart in mice with heart failure with preserved ejection fraction (HFpEF) allowed their hearts to utilize more ketones and produce more energy, according to preliminary ...

The polypill improved left ventricular ejection fraction, reduced hospitalizations, and enhanced quality of life in HFrEF patients over six months. The trial addressed polypharmacy challenges, showing ...